Princeton Portfolio Strategies Group’s Gilead Sciences GILD Stock Holding History

Princeton Portfolio Strategies Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-6,510	Closed	-$466K	–	155
2017 Q4	$466K	Buy	6,510 +44	+0.7%	+$3.34K	0.13%	120
2017 Q3	$524K	Sell	6,466 -3,300	-34%	-$252K	0.14%	127
2017 Q2	$691K	Buy	9,766 +41	+0.4%	+$2.73K	0.2%	105
2017 Q1	$661K	Sell	9,725 -10,208	-51%	-$718K	0.2%	108
2016 Q4	$1.43M	Buy	19,933 +3,060	+18%	+$227K	0.45%	66
2016 Q3	$1.33M	Buy	16,873 +10,567	+168%	+$858K	0.42%	65
2016 Q2	$526K	Buy	6,306 +2,727	+76%	+$242K	0.17%	105
2016 Q1	$329K	Buy	3,579 +328	+10%	+$29.6K	0.11%	118
2015 Q4	$329K	Buy	3,251 +125	+4%	+$13K	0.12%	112
2015 Q3	$307K	Hold	3,126	–	–	0.12%	108
2015 Q2	$366K	Buy	+3,126	New	+$342K	0.13%	105

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Princeton Portfolio Strategies Group's GILD Position: Q1 2018 in Review

Princeton Portfolio Strategies Group sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 6,510 shares — an estimated $466K sold.

Princeton Portfolio Strategies Group first reported a position in GILD in Q2 2015 and held it in 11 quarters. The position peaked at $1.43M in Q4 2016. 1,564 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

Princeton Portfolio Strategies Group reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
Princeton Portfolio Strategies Group sold 6,510 Gilead Sciences shares in Q1 2018, an estimated $466K.
Princeton Portfolio Strategies Group first reported a position in Gilead Sciences in Q2 2015 and held it in 11 quarters.
Princeton Portfolio Strategies Group's Gilead Sciences position peaked at $1.43M in Q4 2016.
1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on Princeton Portfolio Strategies Group's 13F filing for Q1 2018, filed 15 May 2018.